AK0901

· Shanghai Ark Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK0901, covering 2024-04-11 to 2024-04-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD [Phase 3]